Detailed information |
---|
CancerLivER ID | 2263 |
Biomarker | ISGF3G |
Biomarker Name/Symbol (given in Publication) | ISGF3G |
Biomolecule | RNAs |
Subject | Human |
Degree of Validity | Potential prognostic and diagnostic markers for HCC associated with HCV and validated on independent dataset |
Experimental Condition | HCC with Cirrhosis v/s HCC without Cirrhosis |
Cancer type | Hepatocellular carcinoma |
Regulation | Downregulated |
Level of significance | p < 0.05 |
Source | Tissue |
PMID | 18959789 |
Type of Biomarker | Diagnostic and prognostic |
Pathway | Regulation of transcription; Immune response |
Cohort | Paired tumor and non-tumor samples of 17 patients; validation daatset:Ten samples of human DNA and RNA were extracted from PBL and normal liver tissue |
Sensitivity | NA |
Specificity | NA |
Accuracy | NA |
AUC | NA |
Disease | HCV-associated HCC |
Year of Publication | 2008 |
Clinical trial | NO |
Clinical trial (NCT Number) | NA |